Macao vs Singapore: The number of people with susceptibility test result for rifampicin
Macao
98.97
in 2021
Singapore
98.69
in 2021
Macao rank
34th
Singapore rank
35th
The number of people with susceptibility test result for rifampicin over time
- Macao
- Singapore
How they compare
Macao currently reports 98.97 against 98.69 in Singapore, a difference of 0.28.
Across all 5 years both countries report, Macao has been ahead every year.
Macao ranks 34th and Singapore ranks 35th of 146 countries.
Macao has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Macao | Singapore | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 97.98 | 97.43 | 0.5456 | Macao |
| 2020s | 99.25 | 98.42 | 0.8272 | Macao |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Macao or Singapore?
- Macao, at 98.97 against 98.69 in Singapore as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Macao and Singapore?
- 0.28, with Macao ahead.
- How many years of comparable data are there for Macao and Singapore?
- 5 years are reported by both, from 2017 to 2021.
- How do Macao and Singapore rank globally for the number of people with susceptibility test result for rifampicin?
- Macao ranks 34th and Singapore ranks 35th of 146 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid refreshes it automatically from the source and publishes the full history for both places.